|Advanced Oncotherapy will be presenting to investors at the Proactive One2One Forum at the Chesterfield Mayfair Hotel from 6pm on Thursday 26th January. For further information and registration, please click here: http://tinyurl.com/jnas56c|
|Thanks for that daijavu. Yes I think you could be right about the TW effect on the way that AVO respond to things, I just wish they would be more transparent. I do have faith in the system, and like you I wonder what might happen if AVO are unable to take it forward. We will just have to wait and see. I think we'll be able to see a bit more clearly by the end of this quarter.|
|I agree vatnabrekk, but I suspect that TW may have something to do with that. Perhaps if he did not exist AVO might be more prepared to explain things. Since he does exist and is waiting to pounce on their every statement, their reticence is not to be wondered at.
I don't know about you, but my experience is that when faced with an implacable and irrational enemy, the least ammunition they are given the better.
From my point of view AVO has a world beating piece of kit from a profoundly credible source, have assembled a team of heavyweight professionals to help bring it to market and a production line to supply the expected demand.
They have two main weaknesses. The current lack of a complete working system and a potential lack of funds.
The lack of a system is not new news. We all know about it and if we are not happy with it we should consider our own positions. In any case, it is a situation that should soon be resolved.
The potential cash problem is a more serious matter and could bring the company down. It exists partly because the share price has dropped because raising funds was connected to the share price The drop in the share price can be attributed, at least in part, if not mainly, to TW's activities. Even the Sinophi situation might be connected to his activities in some way because negative news has a habit of receiving more attention than good news. It seems that bringing down small AIM companies is something he specialises in and revels in. Perhaps some of them deserved his attentions but I do not think that AVO does.
What intrigues me is what might CERN do if AVO gets into serious financial difficulties. After all, they created LIGHT, own the patents, are confident it will make existing proton therapy and photon therapy systems obsolete and save many lives throughout the world. Presumably, they have a vested interest in ensuring its success.
That, for what it is worth, is my opinion. You have to form your own.|
|Yes I get that daijavu, but the Sinophi situation still remains unexplained. I appreciate that Sinophi have not cancelled their agreement with AVO and that it is the individual hospitals that have terminated the installation of the machines, but the explanation for that termination given by Sinophi was "due to delays in the proton therapy machine delivery schedules". AVO have not so far commented on these "delays" and in fact they have not clarified the situation relating to Sinophi.
Also, in their RNS dated 24th November they give a date for the Harley Street building as March 2018, but they do not mention a date for installation and start-up of the machine. It is their lack of information that bothers me.|
|Share price seems to be going up on small volumes. Is it being manipulated ahead of a placing i wonder?|
|The original schedule published in November 2014 states that the integration and testing of LIGHT would commence in August 2016 and be followed by the facility and regulatory taking place in Q1/2 2017.
We all know that the facility (Harley Street) is delayed.
On the 30th November 2016, AVO stated that technical development of the first LIGHT system has been proceeding as expected and on the 15th December issued a video demonstrating that the RFQ had been integrated to the proton source and fully tested and that testing was progressing on the remaining components.
Do not forget that all the components of the LIGHT system have already been constructed and individually tested by their manufacturers, are know to work and are at the ADAM facility in Geneva where the complete system is being assembled and tested.|
|In which case there is something very odd about the Sinophi situation, and it ought to be clarified. If everything is on schedule and going according to plan, why has Sinophi said that the installations of AVO's machines were "terminated due to delays in the proton therapy machine delivery schedules"?
And referring to a working prototype capable of commercialisation, why did they say "As this is a new technology, still in the research and development stage, we are unable to predict when this will be achieved.
Something must have changed to cause Sinophi to make these statements on their web site. If the testing of LIGHT is progressing on time, what else has changed since AVO and Sinophi made their original agreement?|
|It's a good job that AVO has one or two things going for it.
The LIGHT machine was developed by CERN to replace the cyclotron and syncrotron machines that CERN previously had a hand in developing. Perhaps CERN might have some idea if the LIGHT machine is likely to replace cyclotrons and syncrotrons since CERN is the world leading authority on both?
CERN owns the patents to the LIGHT machine, has licenced it to AVO and has a vested interest in the success of the project.
CERN is still involved in integrating and testing the LIGHT machine.
I think it also helps that the integration and testing of LIGHT is progressing on time as set out in the original schedule.|
|My understanding is that the AVO system is (or will be, when it's fully developed) more technically advanced than Mevion and the others. And scantrader I believe you are wrong in your statement about this, but I stand to be proved wrong.
However, although I do actually have faith (ultimately) in the AVO system, they have not yet answered the outstanding issues (please don't ask what they are, they have all been well documented on these boards) and they have been very naughty in avoiding these issues. So I won't be investing any more in this company until the management come clean.|
|Btw I rather agree with your view that "you don't think TW has as much killer evidence as he believes" re the fraud issue. AIM regs seem so slack I reckon he'd need an email
from AVO begging Sinofi to hold off formally ending the contracts until they'd got a placing away !
My bear case here - and his I think - is more broadly based than that.|
|As for copying and pasting between the boards why should I bother all the time, especially when a lot of you (I think) do check other bbs ?|
|gerhart - in this case I don't think there was a notifying threshold.
(Edit - do correct me if I'm wrong)|
|Firstly Scan I am genuinely not a ramper. And I agree the Co should be, and have been more honest/open about current situation - in so far as they can.
But I don't think TW has as much killer evidence as he believes. Maybe he has more and maybe I'll be wrong.
As for your own posts - why tell us you have posted elsewhere, when you could have simply done what you have now?! Copy and paste.
And finally I think that your credibility is badly damaged on this point alone: The significant holder's small percentage increase that I don't think needed an RNS declaration.
The FACT is anyone above the notifying threshold have to inform about ALL transactions.
I disagree with some of your other comments. But that doesn't make me a ramper.
|TW is clearly running out of steam and is in the typical journalist game of the re-hash. He has to save face now before someone clobbers him with something legally nasty, not that it will do him any good. In any case what we think here is largely irrelevant as it is the II's only that count.|
|scantrader, you are TW and I claim my £5!|
|And may as well paste this one too ...
Over the next few years,Today 06:12and before LIGHT has been built, proved to be reliable and with regulatory approval, it beats me why any hospital would want to place a firm order when they can get a compact, perfectly adequate and well proven one from Mevion/ IBA/maybe Hitachi.
As part of its PR spin I think AVO has encouraged its investors to think of a binary divide between heavy giant cyclotrons and their LIGHT machine. Don't fall for it – their relevant competition now is with compact superconductor synchro-cyclotrons.
Recall my recent posts about 90% of hospitals choosing competitor systems even in 10 years time. (If it ever gets to market).
That alone should make you question the alleged superiority of LIGHT.|
|Oh well - I see gerhart at least is someone who doesn't read the LSE board, so I'll paste this from over there
Ramping before a big fund raising?Today 06:09
Are you guys really not rather suspicious about all the company ramping recently?
The new promo video on the website.
The significant holder's small percentage increase that I don't think needed an RNS declaration.
The director buys – little ones eked out day by day for maximum effect on the share price
(Note how the naïve/ramper posters would obligingly comment on how much faith he must have in the company/ he knows its worth if anyone does etc. In fact the expected share price increase more than compensates for his purchases and pushing up the share price means that the placing price in a fund raising – and thus the value of his overall holding - is likely to be that much higher .)
The upcoming invitation to the site for analysts being talked about.
Re- hashing of old news and spin about how LIGHT is better than legacy machines. (Who cares?
They won't be competing with those, yet they know that a lot of private investors will assume in a sloppy way that they are. At least they spared us the old football pitch v bus analogy this time though.)|
|I think TW is going to have real difficulty making a negative case here at the moment because of the recent NED regular buying and also, perhaps particularly, because of Segulah's buying.
They know the company from "the inside", and wouldn't be chucking money down the drain.|
|New article from TW
|Financing can't be happening at the moment, or the Director wouldn't be allowed to be buying shares (assuming that they decided to follow the rules for a change).|
|More to the point, what happened to the financing update promised by end 2016?|
|I've put some new posts for anyone interested over on the LSE board for anyone who doesn't follow that board closely.|
|Ticking up nicely this morning.|
|Succinctly put Twirl. Having closed most of my short position here a while back
I now find I can't re-open one anywhere. Irritating - I should have hedged rather than
|Failure to meet testing and financing timetables indicates delay and funding issues with further dilution or hard ball debt.|